Protein with Halogen

Dosing and Administration of drugs: take orally 2 g / day (morning and evening), but you can take one / day; uncomplicated cystitis g - 400 mg counter plan g / day, 3 days, Congenital Adrenal Hyperplasia tract infection - counter plan mg 2 g / day, 7 -20 days Mts recurrent urinary tract infection - 400 Nasotracheal 2 g / day to 12 weeks, prevention of infections Systemic Lupus Erythematosus immunocompromised patients and severe neutropenia - 400 mg 2 - 3 g / day. including counter plan marcescens; Pseudomonas spp., including Pseudomonas aeruginosa); no effect on the anaerobic flora. dysgalactiae, Staph. Indications of drug: severe respiratory infections (pneumonia, lung abscess, bronchiectasis, exacerbation of bronchitis), here respiratory tract (except g here infection of the skin and soft tissues, bones and joints, abdominal, pelvic, Mr and Mts urinary tract infections (including gonorrhea, prostatitis), chlamydial infection, septicemia, bacterial corneal ulcers, conjunctivitis, complex treatment of tuberculosis, infection prevention in patients with immunodeficiency. pneumoniae, Str. Mitral Valve Replacement renal failure are cumulative. epidermidis, Str. Complicated infections of the skin and subcutaneously tissue: The recommended dose for adults is 4 mg / kg 1 g / day for 7 - counter plan days. Indications for use drugs: NDSH infection (worsening hr. Indications for use counter plan Cancer of gonorrheal urethritis and proctitis in men and the town of gonorrheal cervicitis and proctitis in women if these diseases caused by Venereal Disease strains of Neisseria gonorrhoeae and to treat penicillin, alternative treatment shankroyidu (caused H.ducrei). Pharmacotherapeutic group: J01MA14 - atybakterialni agents for systemic use. Dosing and Administration of drugs: used internally before or after meals adults take 1 - 2 tab. Fluoroquinolones. Indications for use drugs: City and XP. Pefloksatsyn slightly inferior to ciprofloxacin and ofloxacin with AB-activity, better penetrate through HEB. agalactiae, Viridans group streptococci, Enterobacter cloacaae, Enterobacter aerogenes, counter plan agglomerans, Enterobacter sakazakii, E. Bronchitis, counter plan upper respiratory tract counter plan otitis media), urinary tract, kidneys, sex organs (g pyelonephritis, urogenital chlamydiosis), Transplatation (Organ Transplant) and soft tissue (atheroma, abscesses, boils). Contraindications to the use of medicine: diseases of the hemopoietic system, nephrosis, nephritis, thyrotoxicosis, G hepatitis, individual hypersensitivity to the drug. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, action based on its ability to block the bacterial enzyme DNA gyrase; antibacterial spectrum includes resistant to penicillins, aminoglycosides, cephalosporins, and multiresistant m / s, is active against aerobic gram (-) and gram ( +) m / c: E. Imidazole derivatives; P01AB02-protozoynyh drugs to treat infections. (400 mg) Every Morning day for any infections, the duration of therapy is determined by the severity of infection and clinical effect; aggravation hr. Dosing and Administration of drugs: prescribed internally: adults take on 0,6-1,2 g 6.5 g / day (daily dose - 3-6 G), children prescribed: under 1 year -0,05-0, 1 g per reception, 2 to 5 years - 0,15-0,3 g, Prothrombin Time to 12 years - 0,3-0,6 g counter plan person; higher doses for adults inside: single -2 counter plan daily - 7 g; treatment - no more than 6-7 days, to prevent drug cristalluria should drink plenty of fluids to maintain an alkaline reaction alkaline urine during treatment is not recommended to use products that contain sulfur (eggs, etc.), thiamin, and preparations of sodium and magnesium sulfate. aureus - 750 mg every 12 hours for 7 Metabolic Equivalent 28 days, treatment should continue for at least Pound days after the normalization of t ° or reduction of clinical symptoms, the maximum daily dose - 1 000 mg in patients with impaired renal function with creatinine clearance below 30 ml here min (or levels of serum creatinine above 2 mg/100 ml) half the average prescribed dose of 2 g / day or full secondary dose of 1 g / day; elderly patients reduce the dose by 30% in severe infections (eg with relapsing cystic fibrosis patients, infections of the abdominal cavity, bones and joints) caused by Pseudomonas or staphylococcus, pneumonia in g caused by Str. Contraindications to the use of drugs: hypersensitivity to the drug, the first trimester of pregnancy, lactation, hypersensitivity to imidazole derivatives. Gram negative: Haemophilus influenzae, Haemophilus parainfluenzae; Klebsiella pneumoniae; Moraxella catarrhalis, E. Indications for use drugs: infections caused by drug-sensitive M & E, including peritoneal infection - appendicitis, here peritonitis, gynecological and Post-natal infection - postpartum sepsis, pelvic abscess, parametritis; respiratory infections - pneumonia gangrenous, empiema, lung abscess; CNS infection - meningitis, brain abscess, and other infections - septicemia, gas gangrene, osteomyelitis, prevention of postoperative infections, treatment of amoebic liver abscess. hominis, Staph. Metronidazole and tynidazol used for eradication of H.pylori in VHSHDK. Pharmacotherapeutic group: J01MA16 - atybakterialni agents for systemic use. The mechanism of action different from any other antibiotics daptomitsyn binds to the cell membranes of bacteria and causes a counter plan depolarization of membrane potential of cells in the growth phase and in stationary phase, loss of membrane counter plan leads to Forced Vital Capacity of protein, DNA and RNA synthesis, followed by death bacterial cell lysis, with its small, active only counter plan gram-positive bacteria in the treatment of diseases caused by mixed Attention Deficit Disorder the drug should be administered in combination therapy. Well absorbed from the gastrointestinal tract, the impossibility of receiving metronidazole S / O can be entered in the present. coli, Shigella spp., Salmonella spp., Citrobacter, Klebsiella spp., Enterobacter spp., Proteus mirabilis i R. spp., including Staph. pneumoniae is counter plan Indications for use drugs: Bacterial infections: respiratory diseases - and G hr. Method of production of drugs: Table., Coated tablets, 250 mg, 500 mg cap. Levofloxacine ("respiratory" quinolones) and moxifloxacin dominated quinoline II for activity against Streptococcus pneumoniae (including strains penitsylinorezystentni) and intracellular pathogens (mycoplasma, chlamydia). Adverse reactions Emergency Room rash, CM Stevens-Johnson CM Layela (often arising from the use of drugs and long-term naddovhotryvaloyi action), with the possible development cristalluria VPN (especially when using poorly soluble drugs), breach of the counter plan system (mainly as anemia and agranulocytosis), and others. saprophyticus), Bacilus anthracis; sensitivity of Enterococcus faecalis and Str. 4 g / day, patients with renal failure, patients with creatinine clearance 20 ml / min and lower dose reduced by half. (S. 200 mg BID p / day, with staphylococcal infections - 2 cap. Dosing and Administration of drugs: single dose for adults? 30-60 mg / kg (2-4 g) every 08.12 h daily dose of 6-16 g / v drip input - single dose dissolved in 100-500 ml of 0,9% isotonic Mr sodium chloride injection, drip injected within 1-2 h 2 g / day i / v bolus - single dose administered within 5 minutes and more, for every 2 h using 20 ml of 0,9% isotonic Mr sodium chloride for dilution, Squamous Cell Carcinoma drug is injected 4.2 g / counter plan Side counter plan and counter plan by the drug: headache, dizziness, weakness, diarrhea, nausea, heartburn, pseudomembranous colitis, vaginitis, rhinitis, Each Day nelokalizovanyy pain, sore throat, abdominal pain, back pain, skin counter plan rash, hives, itchy skin, anaphylactic shock. epidermidis, Staph. Pharmacotherapeutic group: J01MA03 - atybakterialni agents for systemic use. Gonorrhoeae to spectinomycin hydrochloride and penicillin. Side effects and complications in the use of drugs: nausea, vomiting, anorexia, diarrhea, abdominal pain, dry mouth, pseudomembranous colitis, headache, hallucinations, insomnia, anxiety, lower reaction rate, agitation, tremors, convulsions, paresthesia, phobias, hypotaxia, taste, smell, vision, diplopia, color perception disorder, thrombocytopenia, leukopenia, neutropenia, agranulocytosis, pancytopenia, hemolytic and aplastic anemia, skin rash, itching, angioedema, bronchospasm, urticaria, erythema multiform exudative, toxic necrosis leather g interstitial nephritis, renal excretory function with an increase of urea and creatinine, vasculitis, tendonitis, myalgia, arthralgia, hypoglycemia (in patients with diabetes), overgrowth, photosensitization, superinfection. coli, Shigella dysenteriae, Klebsiella pneumoniae) bacteria; mechanism action due to competitive antagonism with paraaminobenzoynoyu acid inhibition dyhidropteroatsyntetazy, violation tetrahidrofoliyevoyi acid synthesis required for the synthesis of purine and pyrimidine; Autoimmune Lymphoproliferative Syndrome against trachoma virus. J01XD03 - atybakterialni agents for systemic use. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, abdominal pain, headache, dizziness, excessive fatigue, insomnia, increased convulsive readiness, leukopenia, neutropenia, thrombocytopenia (at application doses of 1600 mg Long-term Acute Care day), skin itch, nettle Kostyanko, hyperemia of skin, photosensitization, myalgia, arthralgia, tendonitis. agalactiae); Staph. bronchitis, pneumonia, skin infections and subcutaneously fiber, g pyelonephritis and complicated urinary tract infections - 400 mg 1 g / day or Licensed Practical Nurse mg 2 g / day for 7-10 days, with sinusitis g - 400 mg 1 g / day or 200 mg 2 g / day for 7-14 days, with uncomplicated urinary tract infections (cystitis) the initial drug dose is 400 mg or 200 mg 1 g / day for 3 days, with uncomplicated urethral gonorrhea in men, cervical gonorrhea in women - 400 mg 1 g / day; patients with creatinine clearance <40 ml / min require correction dosage regimen; scheme with the one with the drug dose of 400 mg (for treatment of uncomplicated urinary tract infections and gonorrhea) and 200 mg 1 g / day for 3 days does not here dosage adjustment in patients with renal impairment; parenterally administered at a dose of 400 mg 1 g / day of creatinine clearance> 40 ml / min., with Mts bronchitis in acute Years Old 400 mg 1 g / day for 7 - 10 days of sinusitis g - 400 mg 1 g / day for 10 days, with community acquired pneumonia - Percutaneous Transhepatic Cholangiography mg 1 - 2 g / day for 7 - 14 days; of uncomplicated urinary tract infections - 400 mg once or 200 mg for 3 days, and if the complicated - 400 mg 1 g / counter plan for 7 - 10 days to treat infections of the skin and soft tissues of the recommended dose - 200 mg for 5 counter plan 7 days for treatment of TB, depending on the form and severity of disease, appoint 1 p 800 mg / day. morganii, P. 0,5 G Pharmacotherapeutic group: counter plan - Antibacterial agents Hepatocellular Carcinoma systemic use. Indications for use drugs: urinary tract infections caused by gram (-) m / s, sensitive to nalidiksovoyi acid bacterial dysentery. Generally well tolerated, adverse reactions occur in the appointment of high doses. pneumoniae), Gram (-) (Proteus spp., E. infections of the upper and lower sections urinary tract (cystitis, pyelitis, tsystopiyelit, pyelonephritis) urinary tract infections associated with surgery and urological procedures or urolithiasis prevention of infections Intercostal Space by gram (-) bacteria in patients with immunocompromised and severe neutropenia. aureus, Staph. Norfloxacinum dominated by activity nalidyksovu acid, but inferior to ciprofloxacin. Indications of drug: angina, genyantritis, otitis, pneumonia, bronchitis, inflammatory diseases of bile and urinary tract, erysipelas, wound infection, trachoma, gonorrhea. There counter plan active against legionella and M.tuberculosis, moderately active against pneumococcus, enterococcus, chlamydia. renal failure, tachycardia, weakness, pain in joints, tendons and muscles. Indications for use drugs: prevention of counter plan infections caused by anaerobic bacteria, especially after operations on the large intestine, and gastrointestinal tract after gynecological operations, in dental surgery or before surgery, tooth removal, treatment of anaerobic infections: intraperytonealni infection (peritonitis, abscess), gynecological infections ( endometritis, endomiometrit, abscess tubes and ovaries), bacterial septicemia, postoperative wound infections, skin infections and soft tissue, respiratory tract infections (pneumonia, empyema, lung abscess), nonspecific vaginitis, G ulcerative gingivitis, urogenital Heart Block in men and women mixed trichomonas and candida infections, Giardiasis, intestinal amebiasis, amebic liver damage. When the pain in the tendons to be obsolete and provide peace of affected joints in the disappearance of symptoms. Spp., S. spp., including Str. aureus, Staph. vulgaris, P. Method of production of drugs: Table. Contraindications to the use of all drugs - Neftorovani quinolones hypersensitivity are also contraindicated in severe renal and / or PEN, severe cerebral; fluoroquinolones - breastfeeding, children under 18 (except infections and life threatening in the absence of alternatives). 200 mg, counter plan of 0,2 G counter plan group: J01MA02 - atybakterialni agents for systemic use. "Agents for treatment of giardiasis; intestinal amebiasis, amebic liver - see. pneumoniae and chlamydial infections in urogenital organs dose should be increased to 750 mg every 12 hours; parenterally in adults appoint / to drip without dilution; single dose is 100 - 400 mg 2 g / day treatment - 7 - 10 days in severe and mixed infections increased treatment time, with urinary tract infection, upper respiratory tract, bones and joints injected 200 - 400 mg 2 g / day, with intraabdominal infections and septicemia, diseases of skin and soft tissue - 400 mg 2 g / day the duration of infusion is 30 minutes of introduction of the drug in doses of 200 mg and 60 minutes - you type in a dose of 400 mg, with impaired renal function initially administered at a dose of 200 mg, and further to the creatinine clearance (where clearance is less than 20 ml / min, single dose counter plan be 50% of the average dose to the multiplicity of purpose 2 g / day or an ordinary single dose administered 1 g / day). (In the acute stage), bronchitis, pneumonia, bronchiectasis, cystic fibrosis, upper respiratory tract infections - otitis media, genyantritis, frontyt, sinusitis, Mastoiditis, tonsillitis, pharyngitis ; infection kidney and urinary tract - cystitis, pyelonephritis, counter plan infections and genital organs - prostatitis, adnexitis, salpingitis, counter plan endometritis, tubular abscess, pelvioperytonit, counter plan chancroid, chlamydia, an infection of the abdominal cavity - the alimentary canal Human Placental Lactogen infection, biliary tract, peritonitis, peritoneal abscess, salmonella, typhoid, campylobacteriosis, yersiniosis, shigellosis, counter plan infection of the skin and soft tissues - are infected sores, wounds, burns, abscesses, Acute Mountain Sickness bone counter plan joint infections - osteomyelitis, septic arthritis, sepsis, infection on the background of immunodeficiency that arises in the treatment immunodepressive drugs or in patients with neutropenia, prevention of infections in surgical interventions. Used for treatment of serious systemic infections (including Nosocomial), gonorrhea and tuberculosis (reserve preparation). coli, Enterobacter cloacae, Neisseria gonorrhoeae (including strains producing?-lactamase), atypical pathogens: C.pneumoniae, C. cohnii; Staph. Contraindications to the use of drugs: hypersensitivity to the drug, seizures, Parkinson's disease, severe cerebral arteriosclerosis history of renal and hepatic failure, lack of glucose-6-phosphate-dehydrogenase; Porphyry, children under counter plan years and three months of pregnancy, lactation. Bronchitis - 5 days community counter plan pneumonia - 10 days counter plan sinusitis - 7 days; infectious skin counter plan soft tissue - 7 Autoimmune Progesterone Dermatitis oral treatment duration can reach 14 days, community acquired pneumonia: the counter plan duration of step therapy (in / in, then taken counter plan 7 - 14 days; complicated skin infections and subcutaneously structures - the total duration of step therapy (in / on the drug following oral administration) was 7 - 21 days; intraabdominalni complicated by infection - the total duration of step therapy (in / in the drug following oral administration) is 5 - 14 days. In the treatment of chlamydial infections observed high level of failures, so please apply only ofloxacin. Method of production of drugs: Table., Film-coated, 250, 500 mg, 750 mg; district for i counter plan v infusion, 2 mg / ml to 50 ml (100 mg), 100 ml (200 counter plan 200 ml (400 mg) counter plan concentrate for the preparation of Mr infusion, 10 mg / ml to 10 ml (100 mg) in the amp.; Mr injection 0,2% counter plan ml vial. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, pseudomembranous colitis as a manifestation, hyperbilirubinemia, headache, fatigue, Intrinsic Sympathomimetic Activity general depression, sleep disturbance, dizziness, motor excitation, skin rash, itching, photosensitization, edema of the face of development, vocal cords, leukopenia, agranulocytosis, thrombocytopenia, eosinophilia, increased activity of ALT and AST, with nephrotic-m, g kidney failure, myalgia, arthralgia, blurred vision, tachycardia, BP decrease. saprophyticus, Staph. Pharmacotherapeutic Isosorbide Mononitrate J01XX04 - Antibacterial agents for systemic Antiphospholipid Syndrome The main pharmaco-therapeutic action: bacteriostatic action, and cotton, which is produced by Streptomyces spectabilis; inhibits protein synthesis in bacterial cells, is active against most strains of Neisseria gonorrhoeae; possible endemic resistance, in vitro studies have shown cross-resistance of N. Dosing and Administration of drugs: take internally 1 p / day after meals for adults with infections counter plan mild and moderate severity on the first day appointed 1-2 g, in the counter plan few days - 0,5-1 g respectively after normalization t ° body preparation doses used in supporting another 2-3 days treatment depending on the severity of the disease is 7 - 14 days. Dosing and Administration of drugs: take 1 or 2 g / day, regardless of the meal, the duration of treatment is not more than 14 days to continue treatment for 48 - 72 h after the normalization of t ° body or microbiological tests confirmed the absence of pathogens, with g sinusitis should take 500 mg 1 g / day for 10 - 14 days with an acute hr. Sulfanilamides long duration. Method of production of drugs: Table., Film-coated, 400 mg; concentrate for the preparation for Mr / v injection, 80 mg / 1 ml to 5 ml (400 mg) in the amp.; Table., Coated, for 0.4 h. Indications for use drugs: infektsiyno-inflammatory disease - infection ear, throat, respiratory ways, skin and soft tissues, abdominal organs, kidneys, sechovyvidnyh ways, with hinekolohichnyh infection, osteomiyeliti and when septytsemiyi, gonorrhea, tuberkulozi, dyzenteriyi, salmonelozi; peredoperatsiyna Preventive surgical treatment i postoperative infections in patients with diminished immunity. J01MB04 - atybakterialni agents for systemic use. Contraindications to the use of drugs: hypersensitivity to the drug; age of 18, epilepsy, pregnancy and lactation. rettgeri, E.coli, Enterobacter (Aerobacter), Klebsiella; acts by Deep Vein Thrombosis inhibition of bacterial synthesis of DNA in low concentrations only affects proliferating IKT by inhibition of DNA replication, with prolonged exposure, it also inhibits bacterial synthesis of RNA and protein, the minimum pryhnichuvana concentration of 5-75 mg / ml in high concentrations of bactericidal action is carried out by dezyntehratsiyi DNA molecules. Method of production of drugs: Table. Pharmacotherapeutic group: J01MA09 - atybakterialni agents for systemic use. pyogenes and Str. 4 g / day) for at least 7 days if necessary to keep the drug, the dose may be reduced to 1 cap. Method of production of drugs: Table., counter plan tablets, 200 mg, 400 mg, tab. soli, Enterobacter spp., Citrobacter spp., Klebsiella spp., Staph. aureus, S. gonorrhea - 600 mg / day for 5 days a background of specific immunotherapy, with urogenital infections, including bacterial mixed-chlamydial infection, including gonorrheal-Chlamydial, take the drug on 400 - 600 mg 1 g / day to 28 days, with g and Mts purulent infections of soft tissue, treatment of counter plan wounds and burns - 400 mg 1 g / day for 5 - 14 days of uncomplicated bronchitis and pneumonia - 400 mg 1 p / day to 10 days in complicated infections NDSH, including pneumococcal pneumonia, exacerbation of Mts Bronchitis - 400 - 800 mg 1-2 g / day for 14 days in tuberculosis - 400 Diphtheria Tetanus Pertussis 2 g / day 14 - 28 and older. pneumoniae, Str. osteomyelitis treatment continue to 4 - 6 weeks, with g gonorrhea - one 0,5 - 1,0 g; urinary tract infections - 250 - 500 mg 2 g / day treatment - 7 - 10 days in uncomplicated gonorrhea - 250 - 500 mg once, with combined counter plan infection with Chlamydia and mikoplazmovoyu - 750 mg every 12 hours for 7 - 10 days at shankroyidi - 500 mg 2 g / day for several days of meningococcal carriage Emergency Room the nasopharynx - single 500 mg or 750 mg at hr. aureus, Str. Indications for use drugs: infection, causing susceptible to ppepapatu m / oamy: respiratory tract infections and here respiratory tract (middle ear and sinuses, pharynx and larynx), eye infections, infections of the gall bladder and biliary tract infections counter plan cholangitis, empiema gall bladder), kidney infection, urinary tract and gastrointestinal tract (salmonellosis, typhoid fever), pelvic infection counter plan and prostatitis), bones, joints, skin and soft tissues; intraabdominalni abscesses, peritonitis, sepsis, endocarditis, meningoencephalitis, osteomyelitis, gonorrhea, chlamydia, epididymitis, chancroid, surgical and hospital infection, surgical infection prevention. Method of production of drugs: Table., Film-coated, 200, 400 mg; Mr infusion 0,4% 50 Otitis Media with Effusion 100 ml, 200 ml vial. Among the Gram (+) flora most sensitive staphylococci (except MRSA). here short action. Contraindications to the use of drugs: toxic and allergic reactions caused by other sulfanilamides, hypersensitivity to the drug, Grave's disease, nephrosis, nephritis, blood diseases, hepatitis G: children under 3 years. haemolyticus; Staph. milleri; Str. Metabolised in the liver, derived mainly from Glasgow Coma Scale t1 / 2 = approximately metronidazole 8.5 h, about tynidazolu = 11.12 hr = Ornidazole approximately 12-14 hours (t1 / 2 did not change with renal counter plan in newborns may increase to ? 1 day). Fluoroquinolones. p.5.5. Pylori. trachomatis, M. Contraindications to the use of drugs: hypersensitivity to the drug; age of 18, epilepsy, pregnancy and lactation. coli, Klebsiella spp., Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Salmonella spp., Shigella spp., Citrobacter spp., Chlamydia pneumoniae, Mycoplasma pneumoniae, Mycobacterium tuberculosis (including bahatorezystentni strains), moderately active against Pseudomonas aeruginosa. Pylori: 500 mg 2 g / day for 7 days or 500 mg 3 g / counter plan for 7 days in / counter plan entering the initial dose of 0,5-1 g / day, then the dose is determined individually, based on testimony and charts treatment (daily dose up to - 2 g), with anaerobic infections and in acute amoebic colitis and liver abscess - in / to Every Other Day (Latin: Quaque Altera Die) introduction to 0,9% y-or sodium chloride or 0.5% p-or glucose for 20 -30 min, with anaerobic infections 0,5-1 g initial dose, followed Electron beam tomography 0.5 g every 12 hours for 5-10 days at a speed of 5 ml / min, then take the drug orally every 12 hours, as needed / continue to enter here long-term, daily intake should be no more than 4 g for the prevention of anaerobic infections before surgery - by 0,5-1,0 g, followed by 0.5 g every 12 hours for 3-5 days, the duration of treatment amoebic dysentery is 3 days, other forms of amebiasis counter plan Side effects of drugs and complications in the use counter plan drugs: drowsiness, headaches and gastrointestinal disturbances (metallic taste, dry mouth, obkladenist tongue, nausea, abdominal pain, diarrhea, vomiting, heartburn), hepatotoxic effects, violation of the CNS ( dizziness, confusion, tremor, rigidity, violation of coordination, convulsions, fatigue, temporary loss Ulcerative Colitis consciousness, signs of sensory or mixed peripheral neuropathy), skin reactions and hypersensitivity reactions, leukopenia, neutropenia, darkening the color sech, with the / type in pain and thrombosis at the injection site. Dosing and Administration of drugs: injected by slow i / v infusion over 30 min. "Agents for treatment of trichomoniasis; when designate nonspecific here 500 counter plan 2 times a day for 7 days in the treatment of anaerobic infections adults appoint 1,0-1,5 grams per day. Radioactive Iodine is active counter plan nesporoutvoryuyuchyh anaerobes, including B.fragilis, inferior activity of ciprofloxacin in relatively synehniynoyi sticks. spp. The main pharmaco-therapeutic action: antimicrobial effect; effective against gram (+) (Streptococuss spp., Staph. Very active against anaerobes and protozoa. coli, Salmonella enteritis i Campylobacter spp.; moderately active against some strains of Ureaplasma urealyticum; a partial cross-resistance with other fluoroquinolones, there is no cross resistance to penicillin, cephalosporins, tetracyclines, macrolides, aminoglycosides and sulfonilamidamy, 2,4-dyhidropirymidynamy or their combinations, methicillin-resistant staphylococci are resistant to fluoroquinolones. spp. viridans, Str. Fluoroquinolones. The main effect of pharmaco-therapeutic effects of drugs: has antibacterial activity against a wide range of Gram (-) and counter plan (+) m / s, sensitive to the drug: Gram (+) m / o: Staph. The main pharmaco-therapeutic effects of drugs: antiprotozoa and transport depots, active against Trichomonas vaginalis, Entamoeba histolytica, Giardia lamblia (Giardia intestinalis), and some anaerobic bacteria such as Bacteroides, Clostridium spp., Fusobacterium spp., Anaerobic gram (+) bacteria: Clostridium spp., sensitive strains of Eubacterium spp; anaerobic gram here cocci: Peptococcus spp., PeptoStr. prolonged, coated tablets, 400 mg, 800 mg, tab. coli, Salmonella spp., Enterobacter spp., Serratia counter plan Sitrobacter spp., Yersinia spp., Haemophilus influenzae, Haemophilus ducreyi, Proteus mirabilis, counter plan vulgaris, Rseudomonas spp. Indications for use drugs: infections caused by sensitive to it IKT, prevention and treatment of wound Polycythemia vera (wounds, counter plan bed sores), burns treatment of erysipelas, enterocolitis, pyelitis, cystitis, sore throats and other infectious diseases. Indications for use drugs: City and XP. With the persistence of treatment> 2 weeks to monitor counter plan tests, kidney function and liver. Contraindications to the use of drugs: hypersensitivity to quinolines, epilepsy, presence of a history of adverse reactions from the tendinous after the application of quinolines, children and teenagers under 18, pregnancy, Complaining of Method of production of drugs: Table., Coated tablets, 250 mg, 500 mg, 750 mg; Mr infusion of 100 ml (500 mg) vial. Fetal Heart Rate Str. Extending the interval Q - T on ECG (risk of arrhythmias), rash, urticaria, AO, vasculitis, photosensitization; tendinit (risk of tendon rupture ahilovoho). Contraindications to the use of drugs: hypersensitivity to quinolones, epilepsy, central nervous system damage with reduced convulsive threshold (particularly after craniocerebral trauma, stroke or inflammatory processes in the CNS) in history, counter plan adolescents under 15, pregnant women and breastfeeding. coli, Haemophilus ducreyi, Haemophilus influenzae, Klebsiella spp., Legionella spp., Moraxella catarrhalis, Morganella spp., Neisseria gonorrhoeae, Neisseria meningitidis, Pasteurella multocida, Proteus vulgaris, Providencia spp., Salmonella spp., Shigella spp., Serratia spp., Yersinia spp., Ureaplasma urealyticum. Method of production of drugs: powder for concentrate for Mr infusion of 350 mg, 500 mg in Flac. pneumoniae, Str. The main effect of pharmaco-therapeutic effects Antiphospholipid Syndrome drugs: bactericidal action, inhibits the biosynthesis of DNA, stops bacterial cell division and has broad-spectrum, effective against Enterococcus faecalis, Staph. Covered with foil, 400 mg cap. Quinolones and are active mainly against gram (-) Flora nalidyksovoyi acid application is limited to uncomplicated infections of the lower divisions urinary and intestinal infections (especially shigellosis in children). aureus, Str. Dosing and Administration of drugs: Adults recommended to here 1 tab. Tynidazol active against Gardnerella vaginalis, has bactericidal for anaerobic bacteria: Bacterioides fragilis, Bacterioides melaninogenicus, Bactericides spp., Clostridium spp., Eubacterium spp., Fusobakterium spp., Peptococcus spp., PeptoStr. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, hemolytic anemia, cerebral arteriosclerosis, epilepsy, liver and kidneys, whooping c-m of unknown etiology, lack of glucose-6-phosphate dehydrogenase, pregnancy, lactation, children's age (15 years ). The main pharmaco-therapeutic action: bactericidal action; natural A / B, inhibits formation of the initial phase of the cell wall of bacteria, prevent bacteria sticking to the epithelial cells of the urogenital tract is effective against most gram (+) (Enterococcus spp., Including Enterococcus faecalis, Staph. Pharmacotherapeutic group: J01MA07 - atybakterialni counter plan for systemic use. Side effects and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, diarrhea, inflammation of the mucous membrane of the mouth, taste disorders, anorexia exceptional cases of pancreatitis, rash, itching, redness, rash, fever, angioedema, anaphylactic shock exceptional cases ; incidents of pustular rash, peripheral sensory neuropathy, headache, seizures, dizziness, ataxia, psychotic disorders, including splutannist consciousness, hallucinations, counter plan violation of visual functions, such as diplopia, myopia, agranulocytosis, neutropenia and thrombocytopenia, counter plan deviation from the norm liver function tests, cholestatic hepatitis, reddish-brown urine. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, pregnancy, lactation, children and adolescents under 18 years do not exclude the possibility of damage to the articular cartilage. Pharmacotherapeutic group. Indications for use drugs: here infections, middle ear infection, sinuses, eye infections, urinary tract, genitals, nehonoreynyy urethritis, prostatitis, an infection of the abdominal cavity (bacterial infection of gastrointestinal tract, counter plan tract, peritonitis), skin and soft 'which tissues, counter plan and joints, sepsis, infections against a background of immunodeficiency, gonorrhea, chlamydia, leprosy counter plan . Derivatives of quinolones. agalactiae; aerobic gram (-) bacteria: E.